ArticleNeurology2014
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Alex M Dickens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it